Put Options

15 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2022

Sep 21, 2023

SELL
$13.01 - $27.22 $37,729 - $78,938
-2,900 Reduced 5.48%
50,000 $704,000
Q2 2022

Aug 15, 2022

BUY
$13.01 - $27.22 $650,500 - $1.36 Million
50,000 New
50,000 $705,000
Q2 2021

Aug 16, 2021

SELL
$19.4 - $27.42 $1.03 Million - $1.45 Million
-52,900 Closed
0 $0
Q1 2021

Sep 21, 2023

BUY
$25.02 - $54.99 $32,526 - $71,487
1,300 Added 2.52%
52,900 $1.36 Million
Q1 2021

May 14, 2021

BUY
$25.02 - $54.99 $32,526 - $71,487
1,300 Added 2.52%
52,900 $1.37 Million
Q4 2020

Sep 21, 2023

BUY
$41.04 - $56.79 $2.12 Million - $2.93 Million
51,600 New
51,600 $2.76 Million
Q4 2020

Feb 16, 2021

BUY
$41.04 - $56.79 $1.97 Million - $2.73 Million
48,100 Added 1374.29%
51,600 $2.76 Million
Q2 2020

Nov 02, 2020

BUY
$39.26 - $52.73 $137,410 - $184,555
3,500 New
3,500 $170,000
Q2 2020

Aug 14, 2020

SELL
$39.26 - $52.73 $137,410 - $184,555
-3,500 Closed
0 $0
Q1 2020

Nov 24, 2020

BUY
$31.65 - $46.87 $110,775 - $164,045
3,500 New
3,500 $145,000
Q4 2018

Feb 14, 2019

SELL
$14.32 - $22.92 $644,400 - $1.03 Million
-45,000 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$13.03 - $21.81 $586,350 - $981,450
45,000 New
45,000 $934,000
Q1 2018

May 15, 2018

SELL
$22.47 - $32.33 $2.97 Million - $4.28 Million
-132,300 Closed
0 $0
Q4 2017

Feb 14, 2018

SELL
$26.84 - $39.14 $2.37 Million - $3.45 Million
-88,200 Reduced 40.0%
132,300 $3.98 Million
Q3 2017

Nov 14, 2017

BUY
$29.49 - $38.37 $6.5 Million - $8.46 Million
220,500
220,500 $8.31 Million

Others Institutions Holding ACAD

About ACADIA PHARMACEUTICALS INC


  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.82B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.